CLL is characterized by the clonal expansion of CD5+ CD23+ B cells [2], which is driven by the accumulation of cell-intrinsic aberrations, as well as by the enhancement of B cell receptor (BcR) signaling. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.